• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,421.31 136.24
( 0.17%)
Global Indices
Nasdaq
53,071.47 150.40
(0.28%)
Dow Jones
7,557.54 53.30
(0.71%)
Hang Seng
68,399.59 -1,338.10
(-1.92%)
Nikkei 225
10,649.07 -29.96
(-0.28%)
Forex
USD-INR
95.19 -0.09
(-0.09%)
EUR-INR
108.86 0.10
(0.10%)
GBP-INR
127.02 0.03
(0.03%)
JPY-INR
0.59 0.00
(-0.02%)

EQUITY - MARKET SCREENER

ANG Lifesciences India Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540694
INE236W01016
47.6465918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
42.64
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

themis medicare ltd
NBCC (India) consolidated net profit rises 37.22% in the March 2026 quarter
May 25,2026
Net profit of NBCC (India) rose 37.22% to Rs 241.39 crore in the quarter ended March 2026 as against Rs 175.92 crore during the previous quarter ended March 2025. Sales declined 1.81% to Rs 4559.80 crore in the quarter ended March 2026 as against Rs 4643.85 crore during the previous quarter ended March 2025.

For the full year,net profit rose 33.06% to Rs 720.03 crore in the year ended March 2026 as against Rs 541.13 crore during the previous year ended March 2025. Sales rose 7.01% to Rs 12888.61 crore in the year ended March 2026 as against Rs 12043.78 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4559.804643.85 -2 12888.6112043.78 7
OPM %6.306.27 -4.795.22 -
PBDT346.18347.97 -1 924.23858.41 8
PBT342.29345.01 -1 911.16850.98 7
NP241.39175.92 37 720.03541.13 33